- Home
- FDMT vs FT Comparison
FDMT vs FT Comparison
Compare FDMT & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- FT
- Stock Information
- Founded
- FDMT 2013
- FT 1988
- Country
- FDMT United States
- FT United States
- Employees
- FDMT N/A
- FT N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- FT Trusts Except Educational Religious and Charitable
- Sector
- FDMT Health Care
- FT Finance
- Exchange
- FDMT Nasdaq
- FT Nasdaq
- Market Cap
- FDMT 192.2M
- FT 192.5M
- IPO Year
- FDMT 2020
- FT N/A
- Fundamental
- Price
- FDMT $6.61
- FT $7.96
- Analyst Decision
- FDMT Buy
- FT
- Analyst Count
- FDMT 9
- FT 0
- Target Price
- FDMT $30.63
- FT N/A
- AVG Volume (30 Days)
- FDMT 733.0K
- FT 63.0K
- Earning Date
- FDMT 08-11-2025
- FT 01-01-0001
- Dividend Yield
- FDMT N/A
- FT 7.85%
- EPS Growth
- FDMT N/A
- FT N/A
- EPS
- FDMT N/A
- FT N/A
- Revenue
- FDMT $33,000.00
- FT N/A
- Revenue This Year
- FDMT $9,921.62
- FT N/A
- Revenue Next Year
- FDMT N/A
- FT N/A
- P/E Ratio
- FDMT N/A
- FT N/A
- Revenue Growth
- FDMT N/A
- FT N/A
- 52 Week Low
- FDMT $2.24
- FT $5.97
- 52 Week High
- FDMT $17.41
- FT $7.23
- Technical
- Relative Strength Index (RSI)
- FDMT 57.82
- FT 57.64
- Support Level
- FDMT $5.97
- FT $7.84
- Resistance Level
- FDMT $7.33
- FT $7.97
- Average True Range (ATR)
- FDMT 0.48
- FT 0.10
- MACD
- FDMT -0.11
- FT -0.01
- Stochastic Oscillator
- FDMT 39.51
- FT 78.95
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About FT Franklin Universal Trust
Franklin Universal Trust is a closed-end management investment company. Its primary investment objective is to provide high, current income consistent with the preservation of capital. Its secondary objective is the growth of income through dividend increases and capital appreciation. The fund invests in two asset classes being the high yield bonds and utility stocks.